Home
University & Research Institutions

Sector: University & Research Institutions

Stealthy biotech buys up patent portfolios in string of recent deals

Terran Biosciences has emerged from obscurity to snap up slew of IP rights in the past two months

Columbia University scores $185 million jury verdict on back of anti virus patents

NortonLifeLock has pledged to appeal the jury verdict, which could balloon to $550 million with enhanced damages for wilful infringement

CRISPR FTO complexities not going anywhere in wake of Broad Institute victory, says IP chief on the CVC side

Following major US CRISPR decision, Michael Arciero, VP of IP at ERS Genomics, tells IAM that tricky patent landscapes are the new normal in biotech

Latest content

Lack of mRNA tech transfer “a blessing in disguise” for WHO vaccine team, says Afrigen boss

Petro Terblanche tells IAM about the IP issues surrounding her team’s new replica of Moderna’s covid-19 vaccine

10 February 2022

How platform technologies are reshaping life sciences IP value creation

Versatile biotechnologies are changing patterns of collaboration among healthcare innovators

10 February 2022

Latest Enlarged Board of Appeal referral is a must-watch for US applicants

EPO Board of Appeal seeks clarification on joint applicants approach to priority rights

04 February 2022

IPCom forms alliance with Chinese 5G lab Langbo

The pair say their strategic cooperation will start with in-house patent prosecution services with the potential to grow from there

02 February 2022

CRISPR IP deals continue apace despite legal battles

Spate of recent transactions show the value of gene-editing patents beyond Cas9

28 January 2022

Biden administration is right to pursue a ‘China Initiative’ reset

Even some of the programme’s architects seem to agree that it has strayed from initial focus on trade secrets and intellectual property

22 January 2022

WHO’s vaccine successes show significance of Moderna covid IP pledge

African tech transfer hub is making fast progress in replicating the approved mRNA jab

18 January 2022

Australia under-invests in IP, and recent government proposals will not fix that

Saturday Opinion: In-house leaders say a mooted patent box regime limited to life sciences will reward companies that get patents already, failing to encourage IP investment in new industries

04 December 2021

Data monetisation drives Sanofi’s $180 million investment in AI biotech Owkin

The deal shows how privacy and silo barriers to the commercialisation of information are being overcome

29 November 2021

Nobel laureate’s troubles are a cautionary tale about the importance of university tech-transfer support

Tasuku Honjo’s recent patent battles highlight the potential IP dangers of academic collaborations

18 November 2021

Get unlimited access to all IAM content